AORT Artivion Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AORT

Price (delayed)

$20.85

Market cap

$1.01B

P/E Ratio

80.19

Dividend/share

N/A

EPS

$0.26

Enterprise value

$1.21B

?
Relative Growth: Rel. Growth: 82
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 54
Relative Profitability: Rel. Profitability: 69

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins ...

Highlights
The net income has soared by 155% YoY and by 20% from the previous quarter
Artivion's EPS has surged by 152% YoY and by 18% QoQ
AORT's quick ratio is down by 32% year-on-year but it is up by 4.8% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.cryolife.com
Peers: ABT MDT SYK BSX

Key stats

What are the main financial stats of AORT

AORT stock price

How has the Artivion stock price performed over time
Intraday
1.31%
1 week
-7.62%
1 month
-41.32%
1 year
-27.25%
YTD
-54.29%
QTD
-43.06%

Financial performance

How have Artivion's revenue and profit performed over time
Revenue
$458.69M
Gross profit
$296.1M
Operating income
$30.39M
Net income
$11.69M
Gross margin
64.6%
Net margin
2.5%
The net income has soared by 155% YoY and by 20% from the previous quarter
AORT's net margin has soared by 145% year-on-year and by 14% since the previous quarter
The company's operating income has surged by 93% YoY and by 14% QoQ
The operating margin has surged by 65% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does AORT's price correlate with its fundamentals

Growth

What is Artivion's growth rate over time

Valuation

What is Artivion stock price valuation
P/E
80.19
P/B
2.22
P/S
2.19
EV/EBIT
29.13
EV/EBITDA
17.28
EV/Sales
2.65
Artivion's EPS has surged by 152% YoY and by 18% QoQ
Artivion's equity has surged by 53% YoY
The stock's price to book (P/B) is 47% less than its last 4 quarters average of 4.1 and 29% less than its 5-year quarterly average of 3.1
The price to sales (P/S) is 49% lower than the last 4 quarters average of 4.2 and 23% lower than the 5-year quarterly average of 2.8
The company's revenue rose by 18% YoY and by 3.9% QoQ

Efficiency

How efficient is Artivion business performance
AORT's return on assets has surged by 148% year-on-year and by 8% since the previous quarter
AORT's ROE has soared by 137% YoY and by 13% QoQ
The ROIC is up by 4.3% QoQ
Artivion's return on sales has decreased by 3.2% QoQ

Dividends

What is AORT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Artivion financials performed over time
The total assets is 104% greater than the total liabilities
AORT's quick ratio is down by 32% year-on-year but it is up by 4.8% since the previous quarter
AORT's current ratio is down by 30% year-on-year but it is up by 9% since the previous quarter
AORT's debt is 43% smaller than its equity
The debt to equity has plunged by 54% YoY
Artivion's equity has surged by 53% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.